Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial

Recruiting now · Not applicable

Conditions studied: Ischemic Heart Disease

In brief

Previous randomized clinical trials have deomonstrated the efficacy and safety of short-term dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI), however, the single antiplatelet agent to be maintained after short-term DAPT was different. Therefore, which antiplatelet agent to be maintained after short-term DAPT needs further invstigations.

Key facts

Study ID

NCT05320926

Run by

Yonsei University

People needed

3744

Starts

2022-07-26

Expected to finish

2028-07-10

Last updated by the study team

2024-10-22

Who can join

Age: 19 and older, up to 84. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients ≥19 years
• Patients who received new generation zotarolimus-eluting Onyx stents implantation for treating ischemic heart disease
• Provision of informed consent

You may not qualify if…

• Age ≥ 85 years
• Acute myocardial infarction
• Left main bifurcation requiring 2-stent technique 3. Pregnant women or women with potential childbearing 4. Life expectancy < 1 year 5. Inability to follow the patient over the period of 1 year after enrollment, as assessed by the investigator 6. Inability to understand or read the informed consent

Where it is running

• Yonsei University Health System, Severance Hospital — Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.